Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Vinorelbine as first-line chemotherapy for advanced breast cancer in women 60 years of age or older.

Vinorelbine as first-line chemotherapy for advanced breast cancer in women 60 years of age or older. Ann Oncol. 1999 Apr; 10(4):397-402.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.